This grant, the FY11 Breast Cancer Research Program Clinical Translational Research Award, is for supporting innovative research aimed at significantly improving current approaches to breast cancer prevention and therapy. The Department of Defense seeks projects that will better align treatment options with specific breast cancer subtypes, develop vaccines to prevent primary or recurrent breast cancer, or create new treatments to halt progression to metastasis. The award supports applying promising research findings directly to patients with breast cancer or populations identified as being at risk, with the ultimate goal of making a major impact on clinical outcomes.
Opportunity ID: 107893
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-11-BCRP-CTR |
| Funding Opportunity Title: | DOD FY11 Breast Cancer Research Program Clinical Translational Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 25, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Dec 22, 2011 |
| Current Closing Date for Applications: | Dec 22, 2011 |
| Archive Date: | Jan 21, 2012 |
| Estimated Total Program Funding: | $6,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The FY 11 Breast Cancer Research Program Clinical Translational Research (CTR) Award is intended to promote significant improvements over current approaches to breast cancer prevention and therapy, such as studies that would better align treatment options with more specific breast cancer subtypes, vaccine studies that will prevent primary or recurrent breast cancer, and studies that may result in a new treatment to prevent breast cancer progression to metastasis. The CTR Award supports research projects that are likely to have a major impact on breast cancer by applying promising research findings to patients with, or populations at risk for, breast cancer. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP and eReceipt HELP: 301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 107893 Full Announcement-1 -> bcrp_fy11 ctr pa_gg.pdf
Packages
| Agency Contact Information: | PA HELP and eReceipt HELP: 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00066451 | Jul 25, 2011 | Dec 22, 2011 | View |
Package 1
Mandatory forms
107893 RR_SF424_1_2-1.2.pdf
107893 PerformanceSite_1_4-1.4.pdf
107893 RR_Budget-1.1.pdf
107893 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
107893 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
